Greenwich LifeSciences Ownership 2024 | Who Owns Greenwich LifeSciences Now?


OverviewRevenueFinancialsChart

Institutional Ownership

1.54%

Insider Ownership

52.92%

Retail Ownership

45.54%

Institutional Holders

10.00

Greenwich LifeSciences Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.2.40%0.00%308,909252,450447.14%5,331,769Jun 30, 2024
VANGUARD GROUP INC2.09%0.00%268,16845,06620.20%4,628,579Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.99%0.00%127,68969,445119.23%2,204,159Jun 30, 2024
CREDIT AGRICOLE S A0.68%0.01%87,00087,000100.00%1,501,620Jun 30, 2024
STATE STREET CORP0.53%0.00%68,40355,401426.10%1,180,636,000Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.29%0.00%36,900-600-1.60%636,894Jun 30, 2024
NORTHERN TRUST CORP0.19%0.00%24,3203,10514.64%419,763,000Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.14%0.00%18,45418,454100.00%318,516Jun 30, 2024
MAN GROUP PLC0.13%0.00%16,6505,28546.50%287,379Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.12%0.00%15,29515,295100.00%263,991Jun 30, 2024
MORGAN STANLEY0.05%-7,05382313.21%121,735Jun 30, 2024
RHUMBLINE ADVISERS0.05%0.00%6,7996,799100.00%117,345Jun 30, 2024
BANK OF AMERICA CORP /DE/0.05%-6,32869312.30%109,222Jun 30, 2024
NEW YORK STATE COMMON RETIREMENT FUND0.05%0.00%6,0006,000100.00%104,000Jun 30, 2024
STRS OHIO0.04%0.00%4,8004,800100.00%82,848,000Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.03%0.00%3,2123,212100.00%55,471Jun 30, 2024
JPMORGAN CHASE & CO0.02%-2,548-3,124-55.08%43,978Jun 30, 2024
BARCLAYS PLC0.02%-2,0222,022100.00%35,000Jun 30, 2024
WELLS FARGO & COMPANY/MN0.01%-1,9111,8704560.98%32,984Jun 30, 2024
UBS GROUP AG0.01%-1,8071,405349.50%31,189Jun 30, 2024

Greenwich LifeSciences's largest institutional shareholder is BLACKROCK INC., holding 2.40% of the company's total share outstanding, currently valued at $5.33M. The top 10 institutional shareholders own together 7.56% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CREDIT AGRICOLE S A0.68%0.01%87,00087,000100.00%1,501,620Jun 30, 2024
FOUNDERS CAPITAL MANAGEMENT0.00%0.01%500--8,630Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.29%0.00%36,900-600-1.60%636,894Jun 30, 2024
MAN GROUP PLC0.13%0.00%16,6505,28546.50%287,379Jun 30, 2024
AMERITAS INVESTMENT PARTNERS, INC.0.00%0.00%585585100.00%10,097Jun 30, 2024
STRS OHIO0.04%0.00%4,8004,800100.00%82,848,000Jun 30, 2024
WASHINGTON TRUST ADVISORS, INC.0.00%0.00%200--3,452Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.03%0.00%3,2123,212100.00%55,471Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.99%0.00%127,68969,445119.23%2,204,159Jun 30, 2024
NEW YORK STATE COMMON RETIREMENT FUND0.05%0.00%6,0006,000100.00%104,000Jun 30, 2024
BLACKROCK INC.2.40%0.00%308,909252,450447.14%5,331,769Jun 30, 2024
RHUMBLINE ADVISERS0.05%0.00%6,7996,799100.00%117,345Jun 30, 2024
VANGUARD GROUP INC2.09%0.00%268,16845,06620.20%4,628,579Jun 30, 2024
NORTHERN TRUST CORP0.19%0.00%24,3203,10514.64%419,763,000Jun 30, 2024
GENEOS WEALTH MANAGEMENT INC.0.00%0.00%88--1,519Jun 30, 2024
NORTH STAR INVESTMENT MANAGEMENT CORP.0.00%0.00%51--880Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.14%0.00%18,45418,454100.00%318,516Jun 30, 2024
STATE STREET CORP0.53%0.00%68,40355,401426.10%1,180,636,000Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.12%0.00%15,29515,295100.00%263,991Jun 30, 2024
AMALGAMATED BANK0.00%-207207100.00%4,000Jun 30, 2024

The largest Greenwich LifeSciences shareholder by % of total assets is CREDIT AGRICOLE S A. The company owns 87.00K shares of Greenwich LifeSciences (GLSI), representing 0.01% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.2.40%0.00%308,909252,450447.14%5,331,769Jun 30, 2024
CREDIT AGRICOLE S A0.68%0.01%87,00087,000100.00%1,501,620Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.99%0.00%127,68969,445119.23%2,204,159Jun 30, 2024
STATE STREET CORP0.53%0.00%68,40355,401426.10%1,180,636,000Jun 30, 2024
VANGUARD GROUP INC2.09%0.00%268,16845,06620.20%4,628,579Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.14%0.00%18,45418,454100.00%318,516Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.12%0.00%15,29515,295100.00%263,991Jun 30, 2024
RHUMBLINE ADVISERS0.05%0.00%6,7996,799100.00%117,345Jun 30, 2024
NEW YORK STATE COMMON RETIREMENT FUND0.05%0.00%6,0006,000100.00%104,000Jun 30, 2024
MAN GROUP PLC0.13%0.00%16,6505,28546.50%287,379Jun 30, 2024
STRS OHIO0.04%0.00%4,8004,800100.00%82,848,000Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.03%0.00%3,2123,212100.00%55,471Jun 30, 2024
NORTHERN TRUST CORP0.19%0.00%24,3203,10514.64%419,763,000Jun 30, 2024
BARCLAYS PLC0.02%-2,0222,022100.00%35,000Jun 30, 2024
WELLS FARGO & COMPANY/MN0.01%-1,9111,8704560.98%32,984Jun 30, 2024
UBS GROUP AG0.01%-1,8071,405349.50%31,189Jun 30, 2024
MORGAN STANLEY0.05%-7,05382313.21%121,735Jun 30, 2024
BANK OF AMERICA CORP /DE/0.05%-6,32869312.30%109,222Jun 30, 2024
LEGAL & GENERAL GROUP PLC0.01%-662662100.00%11,430Jun 30, 2024
AMERITAS INVESTMENT PARTNERS, INC.0.00%0.00%585585100.00%10,097Jun 30, 2024

As of Jun 30 2024, Greenwich LifeSciences's largest institutional buyer is BLACKROCK INC.. The company purchased 252.45K stocks of GLSI, valued at $5.33M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC----63,811-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC----41,505-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----17,317-100.00%-Jun 30, 2024
HRT FINANCIAL LP----15,165-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO0.02%-2,548-3,124-55.08%43,978Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.29%0.00%36,900-600-1.60%636,894Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----530-100.00%-Jun 30, 2024
GAME PLAN FINANCIAL ADVISORS, LLC----200-100.00%-Jun 30, 2024
MACQUARIE GROUP LTD----110-100.00%-Jun 30, 2024
OLD POINT TRUST & FINANCIAL SERVICES N A----100-100.00%-Jun 30, 2024
FOUNDERS CAPITAL MANAGEMENT0.00%0.01%500--8,630Jun 30, 2024
WASHINGTON TRUST ADVISORS, INC.0.00%0.00%200--3,452Jun 30, 2024
GENEOS WEALTH MANAGEMENT INC.0.00%0.00%88--1,519Jun 30, 2024
NORTH STAR INVESTMENT MANAGEMENT CORP.0.00%0.00%51--880Jun 30, 2024
FMR LLC0.00%-90--1,553Jun 30, 2024
AMALGAMATED BANK0.00%-207207100.00%4,000Jun 30, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM0.00%-433433100.00%7,474Jun 30, 2024
ROYAL BANK OF CANADA0.00%-561561100.00%10,000Jun 30, 2024
AMERITAS INVESTMENT PARTNERS, INC.0.00%0.00%585585100.00%10,097Jun 30, 2024
LEGAL & GENERAL GROUP PLC0.01%-662662100.00%11,430Jun 30, 2024

As of Jun 30 2024, Greenwich LifeSciences's biggest institutional seller is MILLENNIUM MANAGEMENT LLC. The company sold -63.81K shares of GLSI, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CREDIT AGRICOLE S A0.68%0.01%87,00087,000100.00%1,501,620Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.14%0.00%18,45418,454100.00%318,516Jun 30, 2024
BANK OF NEW YORK MELLON CORP0.12%0.00%15,29515,295100.00%263,991Jun 30, 2024
RHUMBLINE ADVISERS0.05%0.00%6,7996,799100.00%117,345Jun 30, 2024
NEW YORK STATE COMMON RETIREMENT FUND0.05%0.00%6,0006,000100.00%104,000Jun 30, 2024
STRS OHIO0.04%0.00%4,8004,800100.00%82,848,000Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.03%0.00%3,2123,212100.00%55,471Jun 30, 2024
BARCLAYS PLC0.02%-2,0222,022100.00%35,000Jun 30, 2024
LEGAL & GENERAL GROUP PLC0.01%-662662100.00%11,430Jun 30, 2024
AMERITAS INVESTMENT PARTNERS, INC.0.00%0.00%585585100.00%10,097Jun 30, 2024
ROYAL BANK OF CANADA0.00%-561561100.00%10,000Jun 30, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM0.00%-433433100.00%7,474Jun 30, 2024
AMALGAMATED BANK0.00%-207207100.00%4,000Jun 30, 2024

Greenwich LifeSciences's largest new institutional shareholder by number of shares is CREDIT AGRICOLE S A, purchased 87.00K shares, valued at $1.50M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC----63,811-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC----41,505-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----17,317-100.00%-Jun 30, 2024
HRT FINANCIAL LP----15,165-100.00%-Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----530-100.00%-Jun 30, 2024
GAME PLAN FINANCIAL ADVISORS, LLC----200-100.00%-Jun 30, 2024
MACQUARIE GROUP LTD----110-100.00%-Jun 30, 2024
OLD POINT TRUST & FINANCIAL SERVICES N A----100-100.00%-Jun 30, 2024

Greenwich LifeSciences's largest sold out institutional shareholder by shares sold is MILLENNIUM MANAGEMENT LLC, sold -63.81K shares, valued at -, as of undefined.

Greenwich LifeSciences Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD VALLEY FORGE FUNDS0.01%4,233--Mar 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%132,440--Jan 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.00%614--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.00%5,921--Mar 31, 2024
Invesco Exchange-Traded Fund Trust II0.00%174,535--Jan 31, 2024
VANGUARD INDEX FUNDS0.00%215,732-50,689-19.03%Mar 31, 2024
AdvisorShares Trust0.00%1,118--Mar 28, 2024
FIDELITY CONCORD STREET TRUST0.00%46,4352,9886.88%Feb 29, 2024
Principal Exchange-Traded Funds0.00%2,391--Mar 31, 2024
Calvert Variable Products, Inc.0.00%316--Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%2,671--Jan 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%1,489--Mar 31, 2024
TIAA-CREF LIFE FUNDS0.00%73--Mar 31, 2024
Global X Funds0.00%1,119--Jan 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%107--Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%602-5,656-90.38%Mar 31, 2024
NORTHERN FUNDS0.00%2,141--Mar 28, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%800--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%132--Mar 31, 2024
RYDEX SERIES FUNDS0.00%39--Dec 31, 2023
VANGUARD WELLINGTON FUND0.00%3,745--Feb 29, 2024
ProFunds0.00%88--Mar 31, 2024
FIDELITY SALEM STREET TRUST0.00%28,595--Mar 31, 2024
PENN SERIES FUNDS INC0.00%200--Mar 28, 2024
VANGUARD SCOTTSDALE FUNDS0.00%13,691--Feb 29, 2024
T. Rowe Price Index Trust, Inc.0.00%134--Feb 29, 2024
RYDEX DYNAMIC FUNDS0.00%22--Dec 31, 2023
VALIC Co I0.00%1,515--Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%538--Mar 31, 2024
Guggenheim Active Allocation Fund0.00%24--Feb 29, 2024
RYDEX VARIABLE TRUST0.00%4--Dec 31, 2023
USAA MUTUAL FUNDS TRUST0.00%78313420.65%Jan 31, 2024
TIAA-CREF FUNDS0.00%9,502--Mar 31, 2024
PROSHARES TRUST0.00%590--Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%162--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%3,500--Mar 31, 2024
ETF Series Solutions0.00%27--Jan 31, 2024
SUNAMERICA SERIES TRUST0.00%451--Mar 31, 2024
iSHARES TRUST0.00%13,450-352-2.55%Mar 31, 2024
EQ ADVISORS TRUST0.00%954-184-16.17%Mar 31, 2024
Meeder Funds0.00%3--Mar 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%652--Mar 31, 2024
PACIFIC SELECT FUND0.00%1,395--Mar 31, 2024
MASSMUTUAL SELECT FUNDS0.00%366--Dec 31, 2023
NATIONWIDE MUTUAL FUNDS0.00%27-8-22.86%Jan 31, 2024
Bridge Builder Trust0.00%680--Mar 31, 2024
PRINCIPAL FUNDS, INC.0.00%729--Feb 29, 2024

Greenwich LifeSciences's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 4.23K shares, compromising 0.01% of its total assets.

Greenwich LifeSciences Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2410-65.52%
31 Mar, 242911.54%
31 Dec, 232613.04%
30 Sep, 2323-
30 Jun, 2323-14.81%
31 Mar, 232728.57%
31 Dec, 222123.53%
30 Sep, 2217-32.00%
30 Jun, 2225-24.24%
31 Mar, 2233-5.71%
31 Dec, 2135-2.78%
30 Sep, 213620.00%
30 Jun, 213066.67%
31 Mar, 211828.57%
31 Dec, 20141300.00%
30 Sep, 201-

As of 30 Jun 24, 10 institutions are holding Greenwich LifeSciences's shares, representing a decrease of -65.52% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 24198,322-69.24%
31 Mar, 24644,80320.31%
31 Dec, 23535,932-0.26%
30 Sep, 23537,344-14.54%
30 Jun, 23628,750-24.02%
31 Mar, 23827,51423.26%
31 Dec, 22671,383-15.31%
30 Sep, 22792,741-23.18%
30 Jun, 221,031,94210.82%
31 Mar, 22931,17916.98%
31 Dec, 21795,986-2.42%
30 Sep, 21815,7280.61%
30 Jun, 21810,815212.38%
31 Mar, 21259,558132.47%
31 Dec, 20111,65440208.30%
30 Sep, 20277-

Greenwich LifeSciences (GLSI) has 198.32K shares outstanding as of 30 Jun 24, down -69.24% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 241.54%6.12%
31 Mar, 245.02%28.84%
31 Dec, 234.17%23.85%
30 Sep, 234.18%17.46%
30 Jun, 234.89%11.80%
31 Mar, 236.44%23.83%
31 Dec, 225.20%13.60%
30 Sep, 226.18%9.70%
30 Jun, 227.99%15.72%
31 Mar, 227.13%18.85%
31 Dec, 216.15%15.54%
30 Sep, 216.29%15.91%
30 Jun, 216.29%152.92%
31 Mar, 212.03%125.61%
31 Dec, 201.27%12596343.75%
30 Sep, 200.00%-

As of 30 Jun 24, Greenwich LifeSciences is held by 1.54% institutional shareholders, representing a 6.12% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 245-68.75%
31 Mar, 24166.67%
31 Dec, 2315150.00%
30 Sep, 236-40.00%
30 Jun, 2310-28.57%
31 Mar, 231440.00%
31 Dec, 221066.67%
30 Sep, 226-66.67%
30 Jun, 221838.46%
31 Mar, 2213-35.00%
31 Dec, 2120-
30 Sep, 2120-20.00%
30 Jun, 212592.31%
31 Mar, 2113-7.14%
31 Dec, 20141300.00%
30 Sep, 201-

5 institutional shareholders have increased their position in GLSI stock as of 30 Jun 24 compared to 16 in the previous quarter (a -68.75% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 241-75.00%
31 Mar, 244-
31 Dec, 234-50.00%
30 Sep, 23814.29%
30 Jun, 237-12.50%
31 Mar, 238-
31 Dec, 228-
30 Sep, 22833.33%
30 Jun, 226-45.45%
31 Mar, 221137.50%
31 Dec, 21814.29%
30 Sep, 217133.33%
30 Jun, 213-
31 Mar, 213-
31 Dec, 20--
30 Sep, 20--

1 institutional shareholders have reduced their position in GLSI stock as of 30 Jun 24 compared to 4 in the previous quarter (a -75.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2410-65.52%198,322-69.24%1.54%6.12%5-68.75%1-75.00%
31 Mar, 242911.54%644,80320.31%5.02%28.84%166.67%4-
31 Dec, 232613.04%535,932-0.26%4.17%23.85%15150.00%4-50.00%
30 Sep, 2323-537,344-14.54%4.18%17.46%6-40.00%814.29%
30 Jun, 2323-14.81%628,750-24.02%4.89%11.80%10-28.57%7-12.50%
31 Mar, 232728.57%827,51423.26%6.44%23.83%1440.00%8-
31 Dec, 222123.53%671,383-15.31%5.20%13.60%1066.67%8-
30 Sep, 2217-32.00%792,741-23.18%6.18%9.70%6-66.67%833.33%
30 Jun, 2225-24.24%1,031,94210.82%7.99%15.72%1838.46%6-45.45%
31 Mar, 2233-5.71%931,17916.98%7.13%18.85%13-35.00%1137.50%
31 Dec, 2135-2.78%795,986-2.42%6.15%15.54%20-814.29%
30 Sep, 213620.00%815,7280.61%6.29%15.91%20-20.00%7133.33%
30 Jun, 213066.67%810,815212.38%6.29%152.92%2592.31%3-
31 Mar, 211828.57%259,558132.47%2.03%125.61%13-7.14%3-
31 Dec, 20141300.00%111,65440208.30%1.27%12596343.75%141300.00%--
30 Sep, 201-277-0.00%-1---

Greenwich LifeSciences Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 08, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy2,000$13.81$27.62K5,534,602
Aug 07, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy5,500$13.18$72.49K5,532,602
Aug 05, 2024Thompson Jayeofficer VP Clinical Reg AffairsP-PurchaseBuy1,000$15.15$15.15K262,348
Jul 24, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy1,500$15.89$23.84K5,527,102
Jul 22, 2024Thompson Jayeofficer VP Clinical Reg AffairsP-PurchaseBuy1,000$16.00$16.00K261,348
Jun 17, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy174,825$14.30$2.50M5,525,602
Apr 03, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy3,000$19.08$57.24K5,350,777
Mar 26, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy2,500$19.98$49.95K5,347,777
Mar 22, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy1,500$17.68$26.52K5,345,277
Mar 07, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy30,500$12.49$380.94K5,343,777
Mar 06, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy4,100$13.03$53.42K5,340,277
Feb 21, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy10,800$11.16$120.53K5,336,177
Feb 20, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy12,700$11.07$140.59K5,325,377
Nov 14, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy5,000$10.17$50.84K5,312,677
Nov 07, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy3,500$9.11$31.88K5,307,677
Oct 31, 2023Thompson Jayeofficer VP Clinical Reg AffairsP-PurchaseBuy500$8.57$4.29K260,348
Oct 30, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy2,500$7.97$19.93K5,304,177
Oct 27, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy2,500$7.91$19.77K5,301,677
Oct 12, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy1,000$9.07$9.07K5,299,177
Oct 05, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy2,000$8.63$17.26K5,298,177

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 08, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy2,000$13.81$27.62K5,534,602
Aug 07, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy5,500$13.18$72.49K5,532,602
Aug 05, 2024Thompson Jayeofficer VP Clinical Reg AffairsP-PurchaseBuy1,000$15.15$15.15K262,348
Jul 24, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy1,500$15.89$23.84K5,527,102
Jul 22, 2024Thompson Jayeofficer VP Clinical Reg AffairsP-PurchaseBuy1,000$16.00$16.00K261,348
Jun 17, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy174,825$14.30$2.50M5,525,602
Apr 03, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy3,000$19.08$57.24K5,350,777
Mar 26, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy2,500$19.98$49.95K5,347,777
Mar 22, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy1,500$17.68$26.52K5,345,277
Mar 07, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy30,500$12.49$380.94K5,343,777
Mar 06, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy4,100$13.03$53.42K5,340,277
Feb 21, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy10,800$11.16$120.53K5,336,177
Feb 20, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy12,700$11.07$140.59K5,325,377
Nov 14, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy5,000$10.17$50.84K5,312,677
Nov 07, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy3,500$9.11$31.88K5,307,677
Oct 31, 2023Thompson Jayeofficer VP Clinical Reg AffairsP-PurchaseBuy500$8.57$4.29K260,348
Oct 30, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy2,500$7.97$19.93K5,304,177
Oct 27, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy2,500$7.91$19.77K5,301,677
Oct 12, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy1,000$9.07$9.07K5,299,177
Oct 05, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy2,000$8.63$17.26K5,298,177

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 08, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy2,000$13.81$27.62K5,534,602
Aug 07, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy5,500$13.18$72.49K5,532,602
Aug 05, 2024Thompson Jayeofficer VP Clinical Reg AffairsP-PurchaseBuy1,000$15.15$15.15K262,348
Jul 24, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy1,500$15.89$23.84K5,527,102
Jul 22, 2024Thompson Jayeofficer VP Clinical Reg AffairsP-PurchaseBuy1,000$16.00$16.00K261,348
Jun 17, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy174,825$14.30$2.50M5,525,602
Apr 03, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy3,000$19.08$57.24K5,350,777
Mar 26, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy2,500$19.98$49.95K5,347,777
Mar 22, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy1,500$17.68$26.52K5,345,277
Mar 07, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy30,500$12.49$380.94K5,343,777
Mar 06, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy4,100$13.03$53.42K5,340,277
Feb 21, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy10,800$11.16$120.53K5,336,177
Feb 20, 2024Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy12,700$11.07$140.59K5,325,377
Nov 14, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy5,000$10.17$50.84K5,312,677
Nov 07, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy3,500$9.11$31.88K5,307,677
Oct 31, 2023Thompson Jayeofficer VP Clinical Reg AffairsP-PurchaseBuy500$8.57$4.29K260,348
Oct 30, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy2,500$7.97$19.93K5,304,177
Oct 27, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy2,500$7.91$19.77K5,301,677
Oct 12, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy1,000$9.07$9.07K5,299,177
Oct 05, 2023Patel Snehaldirector, 10 percent owner, officer CEO and CFOP-PurchaseBuy2,000$8.63$17.26K5,298,177

The last insider buy of GLSI was made by Patel Snehal on Aug 08 2024, buying 2,000 shares at $13.81 per share (worth $27.62K).

Greenwich LifeSciences Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20245--
Q2 20242--
Q1 20246--
Q4 20237--
Q3 20237--
Q2 20236--
Q1 202311--
Q4 20229--
Q3 20222--
Q2 202220--
Q1 202210--
Q4 202131300.00%
Q2 20211--
Q4 202061600.00%
Q3 20203127114.81%

5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Greenwich LifeSciences's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20245--
Q2 20242--
Q1 20246--
Q4 20237--
Q3 20237--
Q2 20236--
Q1 202311--
Q4 20229--
Q3 20222--
Q2 202212--
Q1 202210--
Q4 20213--
Q2 20211--
Q4 20206--
Q3 20206--

As of Q3 2024, Insider owners conducted 5 open market buy trades and 0 open market sell trades of Greenwich LifeSciences's stocks.

Greenwich LifeSciences Peer Ownership


TickerCompany
XFORX4 Pharmaceuticals, Inc.
AVXLAnavex Life Sciences Corp.
NXTCNextCure, Inc.
RVPHReviva Pharmaceuticals Holdings, Inc.
DAWNDay One Biopharmaceuticals, Inc.
VRPXVirpax Pharmaceuticals, Inc.
PDSBPDS Biotechnology Corporation
ACXPAcurx Pharmaceuticals, Inc.
TERNTerns Pharmaceuticals, Inc.
INZYInozyme Pharma, Inc.
EYENEyenovia, Inc.
IMMPImmutep Limited
MNOVMediciNova, Inc.
ABOSAcumen Pharmaceuticals, Inc.
ENTXEntera Bio Ltd.
AMLXAmylyx Pharmaceuticals, Inc.

GLSI Ownership FAQ


Greenwich LifeSciences is owned by institutional shareholders (1.54%), insiders (52.92%), and public (45.54%). The largest institutional shareholder of Greenwich LifeSciences is BLACKROCK INC. (2.40% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.01% of total shares).

Greenwich LifeSciences's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, CREDIT AGRICOLE S A, and STATE STREET CORP. The top five shareholders own together 6.69% of the company's share outstanding.

As of Jun 2024, there are 10 institutional shareholders of Greenwich LifeSciences.

BLACKROCK INC owns 308.91K shares of Greenwich LifeSciences, representing 2.40% of the company's total shares outstanding, valued at $5.33M (as of Jun 2024).

As of Jun 2024, VANGUARD GROUP INC holds 268.17K shares of Greenwich LifeSciences (GLSI), compromising 2.09% of the company, valued at $4.63M.

GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of Greenwich LifeSciences. The company owns 127.69K of the company's shares outstanding (worth $2.2M).